Faculty profile

Rongtuan Lin

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Rongtuan Lin

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2024.
Principal investigator on 9 research grants (9 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Influenza Virus Interferons Anti-Viral Innate Immunity Innate Immunity Hsv-1 Tbk1 Traf7 Ubiquitination

Latest papers

SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain.
Oncogene · 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Nature communications · 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Nature communications · 2024

All 66 publications

Latest funding

Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness
CIHR · 2023 · Principal investigator
$100,000
COVID-19 Variant Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
CIHR · 2021 · Co-investigator
$50,000
Sex as a Biological Variable Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
CIHR · 2020 · Co-investigator
$50,000

All 15 grants and awards

66 publications.

SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain.

Yi Q, Han X, Yu HG, Chen HY, Qiu D, Su J, Lin R, Batist G, Wu JH

Oncogene2024

DOI: 10.1038/s41388-024-02944-2 PMID: 38532114

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic AHF, Kress A, Carter-Timofte ME, Holm E, van der Horst D, Kollmann CF, Liu Z, Wang C, Hoang HD, Kovalenko E, Chrysopoulou M, Twayana KS, Ottosen RN, Svenningsen EB, Begnini F, Kiib AE, Kromm FEH, Weiss HJ, Di Carlo D, Muscolini M, Higgins M, van der Heijden M, Arulanandam R, Bardoul A, Tong T, Ozsvar A, Hou WH, Schack VR, Holm CK, Zheng Y, Ruzek M, Kalucka J, de la Vega L, Elgaher WAM, Korshoej AR, Lin R, Hiscott J, Poulsen TB, O'Neill LA, Roy DG, Rinschen MM, van Montfoort N, Diallo JS, Farin HF, Alain T, Olagnier D

Nature communications2024

DOI: 10.1038/s41467-024-55044-w PMID: 39702301

Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Nature communications2024

DOI: 10.1038/s41467-024-48422-x PMID: 38750019

Anthracyclines inhibit SARS-CoV-2 infection.

Wang Z, Pan Q, Ma L, Zhao J, McIntosh F, Liu Z, Ding S, Lin R, Cen S, Finzi A, Liang C

Virus research2023

DOI: 10.1016/j.virusres.2023.199164 PMID: 37379907

Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer.

Yi Q, Liu W, Seo JH, Su J, Alaoui-Jamali MA, Luo J, Lin R, Wu JH

Molecular cancer therapeutics2023

DOI: 10.1158/1535-7163.mct-22-0237 PMID: 37139712

SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.

Xu Z, Choi JH, Dai DL, Luo J, Ladak RJ, Li Q, Wang Y, Zhang C, Wiebe S, Liu ACH, Ran X, Yang J, Naeli P, Garzia A, Zhou L, Mahmood N, Deng Q, Elaish M, Lin R, Mahal LK, Hobman TC, Pelletier J, Alain T, Vidal SM, Duchaine T, Mazhab-Jafari MT, Mao X, Jafarnejad SM, Sonenberg N

Proceedings of the National Academy of Sciences of the United States of America2022

DOI: 10.1073/pnas.2204539119 PMID: 35878012

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells.

Liu Z, Larocque É, Xie Y, Xiao Y, Lemay G, Peloponese JM, Mesnard JM, Rassart É, Lin R, Zhou S, Zeng Y, Gao H, Cen S, Barbeau B

Frontiers in microbiology2022

DOI: 10.3389/fmicb.2022.988944 PMID: 36532440

2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.

Zhao J, Zhang G, Zhang Y, Yi D, Li Q, Ma L, Guo S, Li X, Guo F, Lin R, Luu G, Liu Z, Wang Y, Cen S

Antiviral research2021

DOI: 10.1016/j.antiviral.2021.105209 PMID: 34801588

Mast cells-derived exosomes worsen the development of experimental cerebral malaria.

Huang K, Huang L, Zhang X, Zhang M, Wang Q, Lin H, Yu Z, Li X, Liu XB, Wu Q, Wang Y, Wang J, Jin X, Gao H, Han X, Lin R, Cen S, Liu Z, Huang B

Acta tropica2021

DOI: 10.1016/j.actatropica.2021.106145 PMID: 34562426

Editorial: Sensing DNA in Antiviral Innate Immunity.

Lin R, Xing J, Zheng C

Frontiers in immunology2021First author

DOI: 10.3389/fimmu.2021.644310 PMID: 34276645

Something wrong or missing on this profile? Suggest a correction

Rongtuan Lin

Research

Latest papers

Latest funding

SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain.

Author Correction: Octyl itaconate enhances VSV&#x394;51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Octyl&#xa0;itaconate enhances VSV&#x394;51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Anthracyclines inhibit SARS-CoV-2 infection.

Discovery of a Small-Molecule Inhibitor Targeting the Androgen Receptor N-Terminal Domain for Castration-Resistant Prostate Cancer.

SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation.

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells.

2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.

Mast cells-derived exosomes worsen the development of experimental cerebral malaria.

Editorial: Sensing DNA in Antiviral Innate Immunity.

Frequent collaborators

Tommy Alain

Pnina Brodt

Chen Liang

Jean-Simon Diallo

Nahum Sonenberg

Nathalie Grandvaux

Kevin Petrecca

Morag Park

Jerry Pelletier

Ivan Topisirovic

Mark Basik

Michael Pollak

Kevin Petrecca

Salman Qureshi

Julie St-Pierre

Ivan Topisirovic

Morag Park

Anne Gatignol

Jean-Pierre Routy

Thomas Duchaine

Andrew Smith

Gerald Batist

Gerald Batist

Michael Witcher

Jean-Pierre Routy

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.

Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.